[Makmiror-complex in the treatment of post-radiation infectious vulvovaginitis in cancer patients].

Abstract

The results of clinical trials of Makmiror-Complex for treatment of infectious vulvovaginitis of mixed etiology are discussed. The study group included 15 patients, aged 18-50, who contracted infectious vulvovaginitis of mixed etiology in the course or shortly after radiation and/or chemotherapy for tumors. The drug proved highly effective.

• Authors: T M Borovtsova, S V Krylov, V I Udovichenko
• Journal: Voprosy onkologii (Vopr Onkol) Vol. 42 Issue 6 Pg. 69-71 ( 1996) ISSN: 0507-3758 [Print] Russia (Federation)
• Vernacular Title: Makmiror-kompleks v lechenii postluchevykh infektsionnykh vuvl'vovaginitov u onkologicheskikh bol'nykh.
• PMID: 9123907 (Publication Type: English Abstract, Journal Article)

Chemical References

• Anti-Infective Agents
• Antineoplastic Agents

Topics

• Adult
• Anti-Infective Agents (adverse effects, therapeutic use)
• Antineoplastic Agents (adverse effects)
• Female
• Humans
• Middle Aged
• Radiotherapy (adverse effects)
• Treatment Outcome
• Vulvovaginitis (etiology, microbiology)